GABRG2 rs9302752: Understanding Your Genetic Variant
The rs9302752 variant is located within the GABRG2 gene, which provides instructions for creating a critical component of the brain's inhibitory signaling system. Research links variations in this gene to a spectrum of epilepsy-related conditions, including generalized epilepsy with febrile seizures plus (GEFS+).
What each genotype means
Common genetic profile
This genotype represents the most frequently observed sequence at this position in the GABRG2 gene. Current scientific literature does not identify this specific genotype as a primary driver of epilepsy or altered GABAergic signaling. It is considered the baseline state for this variant in the general population.
This is a common genotype found in a significant portion of the global population.
Common genetic profile
This genotype represents a heterozygous state at this position. While GABRG2 variants are known to be linked to epilepsy syndromes, this specific common variant is not established as a pathogenic mutation in clinical research. It is generally considered a neutral genetic variation.
This genotype is frequently observed across diverse ancestral populations.
Common genetic profile
This genotype represents the alternative homozygous state at this position. There is no current evidence in clinical databases or peer-reviewed research to suggest that this specific genotype confers an increased risk for epilepsy or other neurological conditions. It is regarded as a common, benign variation.
This genotype is found at a moderate frequency in the general population.
What is rs9302752?
The rs9302752 variant is a specific single nucleotide polymorphism (SNP) found within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence. This particular variant is situated in a region of the genome that influences the expression or function of the GABRG2 protein. While many SNPs are common and have no observable effect on health, researchers study variants like rs9302752 to determine if they contribute to differences in how the brain processes electrical signals. Because this variant is common in the general population, it is often investigated in large-scale genetic studies to see if it acts as a modifier for neurological conditions. It is important to note that the presence of a specific genotype at this location does not automatically indicate the presence of a medical condition, as complex traits like epilepsy are influenced by a combination of many genetic and environmental factors.
The Role of the GABRG2 Gene
The GABRG2 gene encodes the gamma-2 subunit of the GABAA receptor. These receptors are essential for inhibitory neurotransmission in the brain, acting as the primary 'brakes' that prevent neurons from becoming overexcited. When GABA, a chemical messenger, binds to these receptors, it allows chloride ions to enter the neuron, which stabilizes the cell and reduces the likelihood of an electrical discharge. The gamma-2 subunit is particularly important because it is required for the proper trafficking and localization of these receptors to the synapse, the junction where neurons communicate. If the GABRG2 gene produces a faulty subunit, or if the expression levels are altered, the inhibitory system may become less efficient. This imbalance between excitation and inhibition is a well-documented mechanism in the development of various epilepsy syndromes, as the brain becomes more susceptible to the rapid, uncontrolled electrical activity that characterizes a seizure.
Research and Evidence
Scientific literature has established a strong connection between the GABRG2 gene and various forms of epilepsy, including genetic epilepsy with febrile seizures plus (GEFS+) and childhood absence epilepsy. While rare, highly penetrant mutations in this gene are often directly linked to severe epilepsy phenotypes. The evidence for common variants like rs9302752 is more nuanced; while the gene itself is a known risk factor, the specific contribution of this common SNP is often studied as part of a broader genetic landscape. Some studies suggest that variants in GABRG2 can influence how patients respond to certain anti-epileptic medications, such as benzodiazepines, which target the GABAA receptor. However, the evidence for this specific SNP is considered moderate, meaning that while it is a subject of ongoing research, it is not currently used as a standalone diagnostic tool. Researchers continue to use functional assays and large-scale genomic data to clarify how these common variants interact with other genetic factors to influence neurological health.
Interpreting Your Information
Understanding your genetic data can be a powerful tool for personal education, but it is essential to maintain perspective. A genetic variant is only one piece of a very large puzzle. For individuals with a family history of epilepsy or those experiencing symptoms, genetic information should always be discussed with a qualified healthcare professional, such as a neurologist or a genetic counselor. They can provide context based on your personal medical history and clinical presentation. If you are currently taking medication for a neurological condition, never make changes to your treatment plan based on genetic reports without consulting your clinician or pharmacist. They are the only ones who can safely evaluate how your genetic profile might interact with specific therapeutic strategies. Genetic testing for epilepsy is a specialized field, and clinical decisions are based on a comprehensive review of your health, not just a single SNP result.
How common is this variant?
The rs9302752 variant is considered a common polymorphism, with its various genotypes appearing frequently across diverse global ancestral populations.
Frequently asked questions
Does having this variant mean I will develop epilepsy?
No. Having a specific genotype for rs9302752 does not mean you will develop epilepsy. Epilepsy is a complex condition influenced by many genetic and environmental factors, and most people with common variants do not have the condition.
Can I use this result to choose my epilepsy medication?
No. You should never use genetic information to make decisions about your medication. Always discuss your treatment options and any genetic findings with your neurologist or pharmacist, who can provide guidance based on your clinical needs.
What is the difference between a common variant and a rare mutation?
A common variant, like a SNP, is found in a significant portion of the population and usually has a small or neutral effect. A rare mutation is much less common and is often more likely to have a direct, significant impact on gene function and health.
Where can I find more information about GABRG2?
You can find reliable information about genes and their functions through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI) Gene database. These sites provide comprehensive, peer-reviewed summaries.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9302752?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.